Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study

To characterize burden of migraine in prevention-eligible patients compared with prevention non-eligible patients in the United States (US). Receipt of preventive therapy was also examined among prevention-eligible patients. This retrospective study utilized data from the 2017 US National Health and...

Full description

Saved in:
Bibliographic Details
Published in:Current medical research and opinion 2021-03, Vol.37 (3), p.443-457
Main Authors: Foster, Shonda A., Balkaran, Bridget L., Cambron-Mellott, M. Janelle, Samaan, Karen, Mason, Oksana, Ye, Wenyu, Rowland, John C., Jaffe, Dena H.
Format: Article
Language:English
Subjects:
Claims
migraine
monthly headache days
National Health and Wellness Survey
prevention-eligible
preventive therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To characterize burden of migraine in prevention-eligible patients compared with prevention non-eligible patients in the United States (US). Receipt of preventive therapy was also examined among prevention-eligible patients. This retrospective study utilized data from the 2017 US National Health and Wellness Survey linked with medical and pharmacy claims. Patients aged ≥18 years who self-reported experiencing migraine and had confirmed evidence of migraine (≥1 medical or pharmacy claim) were included. Prevention eligibility was based on number of headache days in the past 30 days (prevention-eligible: ≥4 and prevention non-eligible:
ISSN:0300-7995
1473-4877
DOI:10.1080/03007995.2020.1865749